CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells
- PMID: 1351433
- PMCID: PMC1554527
- DOI: 10.1111/j.1365-2249.1992.tb06482.x
CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells
Abstract
Respiratory syncytial (RS) virus-specific T cell lines were derived from the spleens of BALB/c mice primed by intranasal infection with RS virus. The lines were expanded by repeated antigenic stimulation in vitro, and separated into CD4+ and CD8+ T cell-enriched fractions by immunomagnetic adhesion. The effects of passive transfer of these fractions into RS virus infected mice were observed. The most severe immunopathological changes were seen in mice receiving CD4+ cells. Transfer of CD4+, CD8+ or both cell fractions caused RS virus-infected mice to become ill and lose weight. Both cell lines caused an increase in the severity of lung pathology (as monitored by bronchoalveolar lavage) with the appearance of lung haemorrhage and polymorphonuclear cell efflux. In addition, recipients of CD4+ cells developed striking pulmonary eosinophilia. In CD4+ cell recipients, 5 x 10(5) cells were sufficient to decrease lung virus titre, whereas 2 x 10(6) CD8+ cells were needed to produce a similar effect. The unseparated T cell line and the CD4+ cell fraction secreted significant amounts of IL-3, IL-4 and IL-5 (P less than 0.001). High levels of IL-2 were produced only by the unseparated T cell line. The CD8+ cell fraction secreted IL-3 only. The results show that, cell-for-cell, CD4+ cells are more anti-viral and more immunopathogenic than CD8+ cells in RS virus infected mice. Such effects may have contributed to the augmented disease seen in some infants vaccinated against RS virus.
Similar articles
-
Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G.Int Immunol. 1992 Apr;4(4):493-500. doi: 10.1093/intimm/4.4.493. Int Immunol. 1992. PMID: 1591217
-
Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.J Virol. 1990 Sep;64(9):4232-41. doi: 10.1128/JVI.64.9.4232-4241.1990. J Virol. 1990. PMID: 2117070 Free PMC article.
-
Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells.J Immunol. 2001 Aug 1;167(3):1379-86. doi: 10.4049/jimmunol.167.3.1379. J Immunol. 2001. PMID: 11466356
-
Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection.J Immunol. 2011 Sep 15;187(6):3145-54. doi: 10.4049/jimmunol.1100764. Epub 2011 Aug 15. J Immunol. 2011. PMID: 21844390 Free PMC article.
-
Distinct types of lung disease caused by functional subsets of antiviral T cells.J Exp Med. 1994 Jan 1;179(1):81-9. doi: 10.1084/jem.179.1.81. J Exp Med. 1994. PMID: 8270885 Free PMC article.
Cited by
-
Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes.Immunology. 2003 Feb;108(2):220-9. doi: 10.1046/j.1365-2567.2003.01566.x. Immunology. 2003. PMID: 12562331 Free PMC article.
-
Contribution of IDO to human respiratory syncytial virus infection.J Leukoc Biol. 2019 Oct;106(4):933-942. doi: 10.1002/JLB.4RU0219-051RR. Epub 2019 May 15. J Leukoc Biol. 2019. PMID: 31091352 Free PMC article. Review.
-
Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves.Immunology. 1996 Jul;88(3):421-7. doi: 10.1046/j.1365-2567.1996.d01-667.x. Immunology. 1996. PMID: 8774360 Free PMC article.
-
Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge.J Virol. 1998 Apr;72(4):2871-80. doi: 10.1128/JVI.72.4.2871-2880.1998. J Virol. 1998. PMID: 9525607 Free PMC article.
-
Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.Front Immunol. 2020 Jul 29;11:1673. doi: 10.3389/fimmu.2020.01673. eCollection 2020. Front Immunol. 2020. PMID: 32849580 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials